In 2023, the hospital discharges for adnexa and eye diseases in the UK stood at 38.3 per 100,000 persons. The forecast from 2024 to 2028 shows a decline, with projected figures of 35.8, 33.1, 30.5, 27.8, and 25.3 respectively. This indicates a year-on-year decrease of approximately 7.4% from 2024 to 2028.
Notably, the compound annual growth rate (CAGR) over these five years implies an average annual decrease of around 7.8%. The decreasing trend suggests that improvements in healthcare protocols, preventive measures, or demographic shifts may influence discharge rates.
- Future trends to watch for include advancements in medical technology and treatment, changes in healthcare policy, and population aging, which could impact both the incidence and hospital management of adnexa and eye diseases.
